Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Understanding-COVID-19_ebook_updated-0723-FINAL-1
The Importance of Natural History Study to Rare Disease Drug Development

Rare disease drug development varies from the pathways seen in more established indications. The sample sizes are often...


(4 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Managing Patient Enrollment in Acromegaly Rare Disease Studies

In rare disease, every patient matters and it is important for CRO and sponsor medical staff to effectively monitor and...


(2 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Challenges Working with Terminally-Ill Patients in an International Rare Disease Study

Pharm-Olam is a clinical research organization (CRO) that has vast experience in rare diseases. To date, we have completed...


(3 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

Natural History - Case Study: Ultra Rare Disease in Subjects Aged 3 Years and Younger

Pharm-Olam is a clinical research organization (CRO) with global reach and deep expertise in rare disease research. Our...


(3 minute read)

Tags: Rare & Orphan Disease

The Future of Rare Disease Research

Pharm-Olam has been taking a closer look at trends in rare disease research. We started off by reviewing an article that was...


(4 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

The Use of Drug Repurposing in Rare Disease Research

At Pharm-Olam, we have been focusing on trends in rare disease research. We reviewed an article from Nature (click here to...


(4 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

The Use of Gene Therapies in Rare Disease Research

At Pharm-Olam, we go the distance in rare disease. Recently, we have been exploring the subject in greater detail. We started...


(4 minute read)

Tags: Rare & Orphan Disease

The Use of Oligonucleotide Therapies in Rare Disease Research

Rare disease research is such a complicated area because it involves every therapeutic area individually and sometimes in...


(4 minute read)

Tags: Rare & Orphan Disease

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.

GDPR_Checklist-cover